Back
RAPT Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
14
RAPT
RAPT Therapeutics
Last Price:
2.89
Seasonality Move:
-0.51%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
41.40
Seasonality Move:
-0.9%
Sell
14
RAPT Therapeutics (RAPT)
is a Sell
Is RAPT Therapeutics a Buy, Sell or Hold?
- The current RAPT Therapeutics [RAPT] share price is $2.89. The Score for RAPT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- RAPT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RAPT Stock Price Chart
What is RAPT Therapeutics's stock price today?
-
The RAPT Therapeutics share price today is $2.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RAPT is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.42
The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
RAPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 22.85 | Sell |
Chaikin Money Flow: | -194847 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.22 - 4.16) | Sell |
Bollinger Bands (100): | (2.52 - 14.7) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | 873891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Buy |
Bollinger Bands (100): | (40.78 - 48.78) | Sell |
RAPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.12 | Sell |
20-day SMA: | 3.54 | Sell |
50-day SMA: | 5.17 | Sell |
200-day SMA: | 13.25 | Sell |
8-day EMA: | 3.15 | Sell |
20-day EMA: | 3.59 | Sell |
50-day EMA: | 5.25 | Sell |
200-day EMA: | 11.93 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.5 | Buy |
20-day SMA: | 40.58 | Buy |
50-day SMA: | 41.51 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 40.23 | Buy |
20-day EMA: | 40.49 | Buy |
50-day EMA: | 41.77 | Sell |
200-day EMA: | 43.33 | Sell |
RAPT Therapeutics Earnings Growth & RAPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.03 per share, an increase this year of $0.60 per share, and an increase next year of $0.10 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
RAPT Therapeutics Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |